When screening our databases for patients for this study, we also identified patients who had history of CML and later developed de novo myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), with low BCR::ABL1 levels (<1% IS). The gene discussed is BCR; the disease is myelodysplastic syndrome.